The Mascarene Aloes are used in the traditional pharmacopoeia against various ailments including cutaneous diseases and as antispasmodics. Scientific evidence to support these claims is non-existent and mainly based on the scientific repute of A. vera. The antioxidant profile of methanolic leaf extracts of A. purpurea Lam., A. tormentorii (Marais) L. E. Newton & G. D. Rowley, A. lomatophylloides Balf. f., A. macra Haw. and A. vera (L.) Burm. f. was studied using the total antioxidant capacity, copper equivalent and superoxide dismutase assays. In vitro cytotoxicity was evaluated on CAD (Cath.-a-differentiated) neuronal cells by the methyl tetrazolium assay, and the neuroprotective profile was assessed using hydrogen peroxide-induced neurotoxicity with the CAD cells. The aloin and vitexin content were determined by high-performance liquid chromatography with diodearray detection. A. purpurea had the highest aloin content (546.6 nmol/g), while A. tormentorii had the highest vitexin content (67.3 nmol/g). A. macra (concentration <0.1 mg/mL) elicited a 10% cytotoxicity effect on CAD cells while other Mascarene Aloes were not cytotoxic. This study validates the antioxidant and neuroprotective potential of Mascarene Aloes focusing on their aloin and vitexin content that are also present in other reputed medicinal Aloes. to Mauritius (Gurib-Fakim, 2003; Marais & Coode, 1978) , as well as A. macra Haw. endemic to Réunion Island and A. lomatophylloides Balf. f native to Rodrigues (Bosser, Cadet, Gueho, Julier, & Marais, 1976; Marais & Coode, 1978; Pailler, Picot, Lavergne, & Strasberg, 2000) . A. purpurea from Réunion has been reported as being a putative hybrid of A. macra and A. tormentorii (Ranghoo-Sanmukhiya et al., 2010) . The indigenous Mascarene Aloes are extensively used in the Mauritian pharmacopoeia to treat cutaneous bacterial infections and boils, and as antispasmodic medications to relieve stomach pains (Gurib-Fakim, 2003) . Various extracts of Aloe species are traditionally and commercially used for both cosmetic and medicinal purposes with very little scientific evidence to support these claims, because they are mostly based on research performed on A. vera (L.) Burm. f. 3 | METHODS
referred to the traditional use of an Aloe species against a nervous system disorder, namely, the use of a leaf decoction of Aloe asperifolia A. Berger as an ailment for epilepsy. A. vera has also been reported to be a therapeutic against Alzheimer's disease and depression, glaucoma, among others (Foster, Hoster, & Saman, 2011 There are many challenges with the use of plants for medicinal applications, and a major issue is the correct authentication of species medicinally, whilst ensuring that the correct plant part is also used.
Furthermore, it is important to chemically characterise the plant preparations used pharmacologically and clinically, because considerable variation can occur in phytochemical profiles. Whilst these issues have been addressed for many herbal medicine preparations (Howes & Simmonds, 2015) , there remain many issues with the identity and composition of plant preparations used as medicines. An additional concern is the use or overexploitation of species that are endangered. 3 | METHODS
| Metabolite extraction
Lyophilised leaf samples (100 mg) of each Mascarene Aloe species were suspended in 10 mL of cold 70% (v/v) methanol, heated under reflux at 60°C for 1 h, sonicated for 15 min and centrifuged for 10 min at 5000 resolutions per minute. The supernatant was filtered (0.45 mm filter) and analysed. For bioassays, the extracts were concentrated by leaving to air dry and the residues were resuspended in 10% (v/v) ethanol and stored at −20°C in aliquots. For all the experiments, dilutions of extracts were performed fresh using a starting concentration of 1 mg/mL on the day of the bioassay.
| High performance-liquid chromatography analysis
The high performance-liquid chromatography (HPLC) analyses were performed using a Waters Acquity H-Class Ultra Performance Liquid Chromatography system. The HPLC operating conditions were as follows: The column was a Waters Acquity BEH C18 (1.7 μm, 100 mm × 2.1 mm) and the solvent system constituted of (A) 10 mm ammonium phosphate (pH 3.0) with methanesulfonic acid and (B) acetonitrile at a flow rate of 0.4 mL/min; the column temperature was 40°C. Initial mobile phase conditions were 5% B, increased to 15% B over 3 min, with a linear increase to 45% B after 12 min. The column was washed with 100% B for 1 min and allowed to reequilibrate to the starting conditions, giving a run time of 20 min.
Detection was achieved by diode array detector, and data were extracted at 260 and 340 nm. Data analysis was performed using Empower 3 software (Waters). The HPLC profiles of A. purpurea (Campos and Markham, 2007) . Calibration curves were constructed at a concentration ranging from 0.1 to 10 mg/mL following HPLC analysis (as described earlier) of the reference compounds (aloin and vitexin) to determine the quantities of these compounds in each of the Aloe samples, based on peak area. cultures. The cell viability was assayed using a standard MTT assay (Abuhamdah et al., 2015; Freshney, 2001 ).
| Preconditioning and neuroprotection study
Survival of CAD cells was assessed after 24 h pretreatment with Aloe extracts (0.01 and 0.1 mg/mL (w/v) followed by 24 h post-treatment with 250 μm H 2 O 2 (i.e. Aloe extracts containing media removed before addition of H 2 O 2 -preconditioning protocol). A second set of experiments were performed when the Aloe extracts containing media was not removed prior to exposure to the H 2 O 2 -neuroprotection method). All the treatments were performed in triplicates.
| MTT cell proliferation assay
The tetrazolium dye MTT (Sigma, UK) was used to assess cell viability as described by Abuhamdah et al. (2015) . Fifty microliters phosphate buffered saline (136.9, 2.68 mm KCl, 4.3 mm Na 2 HPO 4 and 1.4 mm KH 2 PO 4 , pH 7.4) containing a final concentration of 5 mg/mL MTT was added to the cultures and incubated at 37°C and in 5% CO 2 for 2.5 h. The MTT containing medium was then removed, and the surface of the wells was rinsed gently with 300 μL phosphate buffered saline before the application of 250 μL isopropanol. The optical density of 100 μL samples was spectrophotometrically read at 595 nm (Thermo Labsystems Multiskan Ascent, V1.3).
| Statistical analysis
All the experiments were performed in replicates (n = 3-4), and statistical analysis was carried out using one-way analysis of variance as the data were normal. Tukey's test was performed using SPSS 16.0. The values of p < 0.05 were considered to be statistically significant.
4 | RESULTS
| High performance-liquid chromatography analysis
Evaluation of the aloin content showed that A. purpurea originating from Réunion Island was approximately threefold higher in aloin content (546.6 nmol/g) compared with the other Aloe species, except for A. lomatophylloides, in which the aloin content was almost tenfold lower and A. macra, in which aloin was not detected. Vitexin was detected in all the Aloe species under study, with the highest concentration in A. tormentorii (67.3 nmol/g) and the lowest (12.6 nmol/g) in A. vera ( Fig. 1) (Table 1) .
| Antioxidant capacity of the Aloe extracts
The antioxidant activities of the methanolic Aloe extracts based on Trolox and TAC (copper reducing equivalent) are shown in Table 2 . 
| Superoxide dismutase assay
One unit (U) of activity of SOD is defined as the amount of enzyme needed to exhibit 50% dismutation of the superoxide radical.
Treatment with 0.1 mg/mL of the Aloes extracts increased the SOD activities in the CAD cells (Fig. 2) . A. purpurea and A. tormentorii moderately increased the SOD activity by 26.6% and 15.4% in 1 daytreated differentiated cells and 22.5% and 34.3% in 6 days-treated 
| Neuroprotective activity of Aloe extracts vs. H 2 O 2 -induced neurotoxicity in CAD cells
Using the preconditioning protocol, no significant protection against H 2 O 2 -induced cytotoxicity was achieved with the Aloe extracts tested (not shown), but using the neuroprotection protocol, where the Aloe extracts were present throughout the exposure to H 2 O 2 , dose-dependent neuroprotection was observed. Interestingly, the A. macra extract elicited a significant delayed cytotoxicity (not observed at 24 h, Fig. 3b) over the extended 48 h period, which is comparable to the level of cytotoxicity elicited by 24 h H 2 O 2 alone (Fig. 3) , and neuroprotection was not observed (0.01 and 0.1 mg/mL). In contrast, the other Aloe extracts elicited differential significant levels of neuroprotection (Fig. 4) , ranging from 30% to 97%. (Botes et al., 2008) . Furthermore, Asamenew, Bisrat, Mazumder, and Asres (2011) reported the antioxidant activity of the latex from A. harlana Reynolds and its two constituents; an anthrone (aloin) and a chromone (7-O-methylaloeresin A). According to a report by Tian and Hua (2005) , aloin and aloe-emodin that are major components in some Aloe species exhibited antioxidant or pro-oxidant effects on plasmid DNA.
| DISCUSSION
In this study, three different antioxidant assays, which included evaluation for neuroprotection, were used in order to provide a comprehensive prediction of the antioxidant efficacy of the tested Aloe extracts, primarily because the mechanism of action of naturally occurring antioxidants can be diverse. The results revealed that all the Aloe species investigated displayed significant free radical scavenging and reducing activities with a similar range of potencies (Table 2) . As aloin has been previously reported for its antioxidant activity (Tian & Hua, 2005) , the high aloin content in A. purpurea have been associated with many of phytotherapeutic properties (Grace et al., 2013; Ni & Tizard, 2004; Reynolds & Dweck, 1999) .
Henceforth, it can be hypothesised that along with aloin, there are probably other constituents such as polysaccharides and flavonoids Interestingly, despite this similarity in antioxidant potency, the Aloe species displayed a marked variation in their neuroprotective properties with A. vera and A. lomatophylloides being the most and least effective, respectively, which correlated with having the highest and lowest aloin: vitexin ratio (Table 1) . A. vera, in which the lowest vitexin concentration was observed compared with the other species investigated, displayed the most potent neuroprotective effect in this study.
It is, therefore, postulated that the neuroprotection observed could be due to the presence of other chemical constituents. A range of phytochemicals from various other plant species have been associated with antioxidant properties and are suggested to modulate factors associated with neurodegeneration. These have been investigated for their effects on cognitive functions and mechanisms associated with dementia pathology. Such phytochemicals are chemically diverse, and evidence to support their therapeutic relevance for central nervous system disorders is variable, although emerging data are promising (Williams et al., 2011) . It is in this context that we report and compare the antioxidant and neuroprotective potency of the selected Mascarene Aloes.
Earlier literature described some of the effects of A. vera on neuronal activity. Wang, Cao, and Du (2010) Because vitexin has previously been reported as neuroprotective (Abbasi, Nassiri-Asl, Shafeei, & Sheikhi, 2012; Chandrashekara & Shakarad, 2011; Yang et al., 2014) , the low concentration detected in A. vera (compared with the other Aloe species) suggests that other constituents of A. vera may also be important to mediate the neuroprotective effects. Furthermore, with the exception of A. vera, there are limited published data on the chemical constituents of the studied Aloe species; thus, this study reports novel chemical data for these species, which may be correlated with their pharmacological profiles. It should also be noted that from a conservation perspective, the discovery that A. vera showed the highest potency for neuroprotection is of particular relevance to investigate further for its pharmacological potential for neurodegenerative diseases, because this species is not regulated by CITES (2015).
In this study, A. tormentorii and A. purpurea (Mauritius) Réunion also showed neuroprotective characteristics, ranging from approximately 59.6% to 74%, representing a promising source of compounds with potential relevance for use in a range of neurological diseases ( 
